Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham M Amin

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2023
Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat modelMona M Saber, Manal Moustafa Mahmoud, Hesham M Amin, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 27, 2012
An unusual case of aggressive systemic mastocytosis with associated refractory plasma cell myelomaPreetesh Jain, Srdan Verstovsek, Robert Z Orlowski, et al.
Oncotarget|July 16, 2014
The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma modelSuraj Konnath George, Deeksha Vishwamitra, Roxsan Manshouri, et al.
Hematology (Amsterdam, Netherlands)|November 1, 2017
Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK<sup>+</sup> anaplastic large cell lymphomaLinlin Hu, Xiaonan Zhang, Jian Wang, et al.
Oncotarget|July 3, 2015
A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignanciesMary E Irwin, Blake P Johnson, Roxsan Manshouri, et al.
Oncotarget|September 24, 2016
Type I insulin-like growth factor receptor signaling in hematological malignanciesDeeksha Vishwamitra, Suraj Konnath George, Ping Shi, et al.
Leukemia & Lymphoma|November 12, 2013
Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphomaZhiwei Huang, Zhijia Fang, Hong Zhen, et al.
The American Journal of Dermatopathology|July 26, 2002
Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United StatesHesham M Amin, Peter McLaughlin, Cynthia J Rutherford, et al.
Blood|July 11, 2006
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphomaYajun Han, Hesham M Amin, Bevin Franko, et al.
Leukemia Research|August 22, 2013
Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosisMunevver Cinar, FaridSaei Hamedani, Zhicheng Mo, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2023
Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat modelMona M Saber, Manal Moustafa Mahmoud, Hesham M Amin, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 27, 2012
An unusual case of aggressive systemic mastocytosis with associated refractory plasma cell myelomaPreetesh Jain, Srdan Verstovsek, Robert Z Orlowski, et al.
Oncotarget|July 16, 2014
The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma modelSuraj Konnath George, Deeksha Vishwamitra, Roxsan Manshouri, et al.
Hematology (Amsterdam, Netherlands)|November 1, 2017
Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK<sup>+</sup> anaplastic large cell lymphomaLinlin Hu, Xiaonan Zhang, Jian Wang, et al.
Oncotarget|July 3, 2015
A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignanciesMary E Irwin, Blake P Johnson, Roxsan Manshouri, et al.
Oncotarget|September 24, 2016
Type I insulin-like growth factor receptor signaling in hematological malignanciesDeeksha Vishwamitra, Suraj Konnath George, Ping Shi, et al.
Leukemia & Lymphoma|November 12, 2013
Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphomaZhiwei Huang, Zhijia Fang, Hong Zhen, et al.
The American Journal of Dermatopathology|July 26, 2002
Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United StatesHesham M Amin, Peter McLaughlin, Cynthia J Rutherford, et al.
Blood|July 11, 2006
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphomaYajun Han, Hesham M Amin, Bevin Franko, et al.
Leukemia Research|August 22, 2013
Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosisMunevver Cinar, FaridSaei Hamedani, Zhicheng Mo, et al.
Pageof 12